Glen Burkhardt insider trades: PhaseBio Pharmaceuticals (PHAS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Glen reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 23, 2022 | PHAS | ↓ Sell | 11,248 | $0.79 | $9K | Direct | May 24, 2022 (1d) |
| Nov 19, 2021 | PHAS | ↓ Sell | 5,766 | $2.37 | $14K | Direct | Nov 23, 2021 (4d) |
| May 20, 2021 | PHAS | ↓ Sell | 3,811 | $3.29 | $13K | Direct | May 24, 2021 (4d) |
| Nov 23, 2020 | PHAS | ↓ Sell | 3,497 | $3.45 | $12K | Direct | Nov 23, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Glen Burkhardt's insider trades
Glen Burkhardt is SVP of Human Resources at PhaseBio Pharmaceuticals (PHAS). Since Nov 23, 2020, Glen has reported no open-market purchases and 4 sales worth $47K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.